ÂÜÀòÂÒÂ×

Kaltrina Berisha has a diverse work experience spanning multiple companies and roles. Kaltrina is currently working at Stemline Therapeutics as a Sr. Director, Pricing - Market Access, a position they began in October 2022. Prior to that, they worked at Novartis, where they held two roles: Director, Pricing Strategy and Account Management from July 2021 to October 2022, and Director, Deal Analytics and Pricing Strategy from February 2021 to October 2022. Before joining Novartis, Kaltrina worked at Bristol-Myers Squibb as a Pricing Strategy, AD from February 2020 to February 2021. Kaltrina also has experience at Celgene as a Sr. Manager Pricing/Market Access from January 2014 to February 2020. Earlier in their career, Kaltrina worked at Express Scripts as a Manager from November 2007 to January 2014, and at Fidelity Investments as a Brokerage Service Representative from June 2007 to November 2007.

Kaltrina Berisha attended William Paterson University of New Jersey from 2003 to 2007. During this time, they pursued a degree in Business Management.